Viewing Study NCT01307605


Ignite Creation Date: 2025-12-25 @ 3:17 AM
Ignite Modification Date: 2026-01-09 @ 10:48 PM
Study NCT ID: NCT01307605
Status: TERMINATED
Last Update Posted: 2023-06-27
First Post: 2011-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular Lymphoma
Sponsor: Swiss Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SAKK 35/10
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators